WO2005071421A8 - Detection specifique de troponine et de formes modifiees de troponine - Google Patents

Detection specifique de troponine et de formes modifiees de troponine

Info

Publication number
WO2005071421A8
WO2005071421A8 PCT/US2005/000548 US2005000548W WO2005071421A8 WO 2005071421 A8 WO2005071421 A8 WO 2005071421A8 US 2005000548 W US2005000548 W US 2005000548W WO 2005071421 A8 WO2005071421 A8 WO 2005071421A8
Authority
WO
WIPO (PCT)
Prior art keywords
troponin
modified forms
specific detection
interactors
biomolecular
Prior art date
Application number
PCT/US2005/000548
Other languages
English (en)
Other versions
WO2005071421A1 (fr
Inventor
Tai-Tung Yip
Eric Thomas Fung
Original Assignee
Ciphergen Biosystems Inc
Tai-Tung Yip
Eric Thomas Fung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciphergen Biosystems Inc, Tai-Tung Yip, Eric Thomas Fung filed Critical Ciphergen Biosystems Inc
Publication of WO2005071421A1 publication Critical patent/WO2005071421A1/fr
Publication of WO2005071421A8 publication Critical patent/WO2005071421A8/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des méthodes de détection spécifiquement de troponine, de formes modifiées de troponine et d'interacteurs biomoléculaires de celles-ci. Les formes modifiées de troponine comprennent des fragments de troponine. Tous les polypeptides précités peuvent être détectés par exemple par spectrométrie de masse par affinité.
PCT/US2005/000548 2004-01-16 2005-01-07 Detection specifique de troponine et de formes modifiees de troponine WO2005071421A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53691304P 2004-01-16 2004-01-16
US60/536,913 2004-01-16

Publications (2)

Publication Number Publication Date
WO2005071421A1 WO2005071421A1 (fr) 2005-08-04
WO2005071421A8 true WO2005071421A8 (fr) 2005-10-27

Family

ID=34807061

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/000548 WO2005071421A1 (fr) 2004-01-16 2005-01-07 Detection specifique de troponine et de formes modifiees de troponine

Country Status (1)

Country Link
WO (1) WO2005071421A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275923A1 (en) * 2004-03-23 2006-12-07 Hammond David J Methods for reducing the range in concentrations of analyte species in a sample
DE102012223378A1 (de) * 2012-12-17 2014-06-18 Charité - Universitätsmedizin Berlin In-vitro Verfahren und Kit zur Diagnose von akutem Koronarsyndrom
PL3387898T3 (pl) * 2013-03-15 2020-10-19 Mayo Foundation For Medical Education And Research Identyfikacja i monitorowanie immunoglobulin monoklonalnych na podstawie masy cząsteczkowej

Also Published As

Publication number Publication date
WO2005071421A1 (fr) 2005-08-04

Similar Documents

Publication Publication Date Title
WO2007022248A3 (fr) Methodes de detection du cancer, dans lesquelles sont utilises des profils peptidiques
WO2006073782A3 (fr) Capteurs colorimetriques formes de materiaux diacetylene
WO2004050839A3 (fr) Procedes et systemes de detection et d'analyse de variations de sequences bases sur la fragmentation
AP2787A (en) Methods, immunoassays and devices for detection ofanti-lipoidal antibodies
WO2005057166A3 (fr) Detection de proteines et de prions alteres de maniere conformationnelle
AU2003201232A1 (en) Faims with non-destructive detection of selectively transmitted ions
IL186918A0 (en) Spectroscopic method for the detection of analytes
WO2005067582A3 (fr) Procedes et appareil pour identification d'echantillons amelioree utilisant des techniques analytiques combinees
WO2009023184A3 (fr) Bibliothèques universelles de domaines de liaison de la fibronectine de type iii
EP1726944A4 (fr) Cible echantillon ayant un plan traite superficiellement pour maintenir l`enchantillon et procede de fabrication de celui-ci et spectrometre de masse utilisant la cible enchantillon.
EP1623227A4 (fr) Proteines, capteurs et procedes de caracterisation de substances a analyser utilisant ces proteines et ces capteurs
HK1134342A1 (en) Assay apparatuses, methods and reagents
WO2005081908A3 (fr) Reactifs, kits et procedes pour l'immunodetection d'epitopes sur des molecules
GB2419666C (en) Infrared gas analyzer and infrared gas analysis method.
WO2005103229A3 (fr) Mitochondries trasngeniques, cellules et organismes transmitochondriaux et procedes de production associes
AU2005259012A1 (en) Analyte detection system
EP1869226A4 (fr) Détection de nucléoprotéines virales à l'aide d'un biodétecteur à commutation de canal ionique
BRPI0821597A2 (pt) Métodos para quantificar a quantidade de proteína derivada de plasma e proteína recombinante em uma amostra e para diferenciar proteína derivada de plasma e proteína recombinante em uma amostra, e, kit.
WO2008034622A3 (fr) Méthode de détection et/ou de quantification de l'expression d'une protéine cible candidate dans une cellule et méthode d'identification d'une protéine cible d'un modulateur de molécules de petite taille
WO2006099537A3 (fr) Utilisation de systemes d'antigenes a substituts d'anticorps a des fins de detection d'analytes
WO2005071421A8 (fr) Detection specifique de troponine et de formes modifiees de troponine
WO2007053487A3 (fr) Méthodes et dispositifs pour la détection de la souche d'un pathogène
WO2007067557A3 (fr) Procedes pour la determination de nucleotide cyclique
WO2005055812A3 (fr) Biomarqueurs seriques de la maladie de chagas
EP1780531A4 (fr) Analyseur de phosphorylation de peptide ou protéine, programme de discrimination de la phosphorylation, et support d"enregistrement du programme

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WR Later publication of a revised version of an international search report
122 Ep: pct application non-entry in european phase